These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2014-003490-41 A PHASE 2A STUDY ON THE CLINICAL ACTIVITY AND SAFETY OF ACTINOMYCIN-D IN PATIENTS WITH NPM1-MUTATED AML AGED =70 YEARS AND/OR UNFIT FOR INTENSIVE CHEMOTHERAPY, EITHER NEWLY DIAGNOSED OR PREVIOUSLY TRE... 2022-10-31 due-trials
Completed, but no date Terminated 2016-001516-38 Levothyroxine soft-gel efficacy with variation of intaking time in hypothyroidism replacement therapy Valutazione dell¿efficacia della levotiroxina in capsule molli nella terapia sostitutiva dell¿... bad-data
Completed, but no date Terminated 2016-003949-28 Incobotulinumtoxin versus Onabotulinumtoxin in the treatment of patients with overactive bladder syndrome Incobotulinumtoxin A versus Onabotulinumtoxin A nel trattamento dei pazienti con sindrome d... bad-data
Completed, but no date Terminated 2017-000282-68 A phase 2a study of the clinical activity and safety of actinomycin D in patients with NPM1-wild type AML (other than APL) aged = 70 years old and/or unfit for intensive chemotherapy, either newly dia... bad-data
Other 2017-001836-20 STEP-WISE COMBINATION OF OBINUTUZUMAB, VEMURAFENIB AND COBIMETINIB IN PATIENTS WITH HAIRY CELL LEUKEMIA (HCL) PREVIOUSLY TREATED WITH PURINE ANALOGS OR UNFIT FOR CHEMOTHERAPY: A PHASE-2, SINGLE-ARMS, ... not-yet-due
Other 2019-003084-21 A phase-II academic trial testing, in two parallel non-randomized cohorts, the combination of ruxolitinib (JAK1/2 inhibitor) with brentuximab or nivolumab in relapsed or refractory classical Hodgkin l... not-yet-due